← Back to guidelines
Critical Care320 papers

Diffuse intrinsic pontine glioma

Last edited: 4/15/2026

Overview

Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive and universally fatal pediatric brain tumor characterized by diffuse infiltration of the pons without obvious contrast enhancement on imaging 1.

Diagnosis

  • Imaging: MRI is essential for diagnosis, showing characteristic diffuse infiltration of the pons 1.
  • Biopsy: Typically not feasible due to location and risks 1.
  • Histopathology: Not routinely performed due to inoperability 1.
  • Management

  • First-line: No curative treatment; supportive care is primary 1.
  • Adjunctive: Oncolytic viral therapy combined with radiotherapy shows promise in extending survival 1.
  • Radiotherapy: Used in conjunction with oncolytic viruses to enhance efficacy 1.
  • Special Populations

  • Pediatrics: DIPG predominantly affects children, with no specific management variations noted in the provided abstracts 1.
  • Key Recommendations

  • Consider oncolytic viral therapy combined with radiotherapy for potential survival benefits in DIPG patients (Evidence: Weak) 1.
  • Focus on supportive care measures to manage symptoms and improve quality of life (Evidence: Expert opinion) 1.
  • MRI remains the cornerstone for diagnosis due to its ability to visualize diffuse pontine infiltration (Evidence: Moderate) 1.
  • References

    1 . Oncolytic Viral Therapy Is Feasible in Diffuse Intrinsic Pontine Glioma. Cancer discovery 2022. link 2 Ishida M, Gonoi W, Shirota G, Abe H, Shintani-Domoto Y, Ikemura M et al.. Utility of unenhanced postmortem computed tomography for investigation of in-hospital nontraumatic death in children up to 3 years of age at a single Japanese tertiary care hospital. Medicine 2020. link

    Original source

    1. [1]
    2. [2]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG